Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Colorectal Cancer”

365 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 365 results

Testing effectiveness (Phase 2)Study completedNCT01409005
What this trial is testing

Gemcitabine-UFTE Chemotherapy in Refractory Colorectal Cancer

Who this might be right for
Metastatic or Recurrent Colorectal CancerRefractory to Fluoropyrimidine, Oxaliplatin and IrinotecanSalvage Chemotherapy
Seoul National University Bundang Hospital 41
Testing effectiveness (Phase 2)Study completedNCT01290536
What this trial is testing

Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases

Who this might be right for
Colorectal NeoplasmsNeuroendocrine TumorsCholangiocarcinoma+2 more
Nicholas Fidelman, MD 42
Testing effectiveness (Phase 2)Study completedNCT03427411
What this trial is testing

M7824 in Subjects With HPV Associated Malignancies

Who this might be right for
Human Papilloma VirusCervical CancerOropharyngeal Cancer+2 more
National Cancer Institute (NCI) 57
Testing effectiveness (Phase 2)Study completedNCT00073112
What this trial is testing

ABT-751 in Patients With Renal Cell Cancer

Who this might be right for
Renal Cell Cancer
Abbott 60
Testing effectiveness (Phase 2)Looking for participantsNCT05093907
What this trial is testing

Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
BeyondBio Inc. 27
Testing effectiveness (Phase 2)Ended earlyNCT00126451
What this trial is testing

A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)

Who this might be right for
Breast CancerColorectal CancerNon-small-cell Lung Carcinoma
Merck Sharp & Dohme LLC 16
Testing effectiveness (Phase 2)Looking for participantsNCT05319314
What this trial is testing

LYL273 for Patients With Relapsed or Refractory mCRC

Who this might be right for
Colorectal Cancer
Lyell Immunopharma, Inc. 155
Testing effectiveness (Phase 2)Study completedNCT02260440
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Azacitidine in Subjects With Chemo-refractory Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Anuradha Krishnamurthy 31
Testing effectiveness (Phase 2)Looking for participantsNCT06979908
What this trial is testing

A Clinical Study on the Efficacy and Safety of Fruquintinib in Combination With PD-1 Monoclonal Antibody and Chidamide in Refractory MSS Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
The First Hospital of Jilin University 46
Testing effectiveness (Phase 2)UnknownNCT00081536
What this trial is testing

Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

Who this might be right for
Colorectal Neoplasms
Aronex Pharmaceuticals 105
Testing effectiveness (Phase 2)Study completedNCT02651415
What this trial is testing

Phase II Study of Perindopril and Regorafenib in mCRC

Who this might be right for
Metastatic Colorectal Cancer
British Columbia Cancer Agency 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Testing effectiveness (Phase 2)Ended earlyNCT05733611
What this trial is testing

RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC

Who this might be right for
Refractory Metastatic Colorectal CancerpMMRMSS
Replimune, Inc. 5
Testing effectiveness (Phase 2)Study completedNCT05061017
What this trial is testing

Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC)

Who this might be right for
NSCLCMetastatic Colorectal CarcinomaRefractory Melanoma
Diwakar Davar 13
Testing effectiveness (Phase 2)Study completedNCT02280811
What this trial is testing

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

Who this might be right for
Vaginal CancerCervical CancerAnal Cancer+2 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Temporarily pausedNCT07011550
What this trial is testing

Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer

Who this might be right for
Microsatellite-stable Colorectal CancerStandard of CareNivolumab+1 more
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT02848079
What this trial is testing

TAS-OX for Refractory Metastatic Colon Cancer

Who this might be right for
Colorectal Neoplasms
Yale University 41
Early research (Phase 1)Study completedNCT00940758
What this trial is testing

Phase I and Pharmacokinetic Study of Biweekly PEP02 in mCRC Refractory to 1st-line Oxaliplatin Base Therapy

Who this might be right for
Metastatic Colorectal Cancer
PharmaEngine 18
Not applicableStudy completedNCT04920422
What this trial is testing

RE-SEARCH Study: A Study to Learn How and in Which Amount Regorafenib is Given in Usual Practice to Patients in Spain: a Study Looking Back at Cases That Have Already Happened When the Study Begins.

Who this might be right for
Metastatic Colorectal Cancer
Bayer 242
Not applicableStudy completedNCT01996969
What this trial is testing

Identification of Predictive Biomarker of Regorafenib in Refractory Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Seoul National University Hospital 117
Next Page